BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marchioni M, Rivas JG, Autran A, Socarras M, Albisinni S, Ferro M, Schips L, Scarpa RM, Papalia R, Esperto F. Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art. Curr Urol Rep 2021;22:31. [PMID: 33886004 DOI: 10.1007/s11934-021-01050-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Grammatikaki S, Katifelis H, Farooqi AA, Stravodimos K, Karamouzis MV, Souliotis K, Varvaras D, Gazouli M. An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma. In Vivo 2023;37:1-10. [PMID: 36593023 DOI: 10.21873/invivo.13049] [Reference Citation Analysis]
2 Ouzaid I, Rioux-Leclercq N, Khene ZE, Bensalah K, Kammerer-Jacquet SF. Can Molecular Classifications Help Tailor First-line Treatment of Metastatic Renal Cell Carcinoma? A Systematic Review of Available Models. Eur Urol Open Sci 2023;47:12-9. [PMID: 36573246 DOI: 10.1016/j.euros.2022.11.006] [Reference Citation Analysis]
3 Wu X, Iliuk AB, Tao WA. Translational proteomics and phosphoproteomics: Tissue to extracellular vesicles. Adv Clin Chem 2023;112:119-53. [PMID: 36642482 DOI: 10.1016/bs.acc.2022.09.003] [Reference Citation Analysis]
4 Hajiesmailpoor Z, Tabnak P, Ahmadzadeh B, Ebrahimi SS, Faal B, Mashatan N. Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions. Biomedicine & Pharmacotherapy 2022;153:113507. [DOI: 10.1016/j.biopha.2022.113507] [Reference Citation Analysis]
5 Shen T, Song Y, Wang X, Wang H. Characterizing the molecular heterogeneity of clear cell renal cell carcinoma subgroups classified by miRNA expression profile. Front Mol Biosci 2022;9:967934. [DOI: 10.3389/fmolb.2022.967934] [Reference Citation Analysis]
6 Köditz B, Heidenreich A, von Brandenstein M. The Current Status of Kidney Cancer Urine Markers – A Systematic Review. KCA 2022;6:137-142. [DOI: 10.3233/kca-220005] [Reference Citation Analysis]
7 Marchioni M, Amparore D, Magli IA, Bertolo R, Carbonara U, Erdem S, Ingels A, Muselaers CH, Kara O, Mascitti M, Klatte T, Kriegmair M, Pavan N, Roussel E, Pecoraro A, Marandino L, Campi R, Schips L. Potential benefit of lymph node dissection during radical nephrectomy for kidney cancer: A review and critical analysis of current literature. Asian Journal of Urology 2022. [DOI: 10.1016/j.ajur.2022.03.007] [Reference Citation Analysis]
8 Palumbo C, Perri D, Zacchero M, Bondonno G, Martino JD, D'agate D, Volpe A. Risk of recurrence after nephrectomy: Comparison of predictive ability of validated risk models. Urologic Oncology: Seminars and Original Investigations 2022;40:167.e1-167.e7. [DOI: 10.1016/j.urolonc.2021.11.025] [Reference Citation Analysis]
9 Peter MR, Zhao F, Jeyapala R, Kamdar S, Xu W, Hawkins C, Evans AJ, Fleshner NE, Finelli A, Bapat B. Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma. Front Oncol 2022;11:814228. [DOI: 10.3389/fonc.2021.814228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Fasanella D, Antonaci A, Esperto F, Scarpa RM, Ferro M, Schips L, Marchioni M. Potential prognostic value of miRNAs as biomarker for progression and recurrence after nephrectomy in renal cell carcinoma: a literature review. Diagnosis (Berl) 2021. [PMID: 34674417 DOI: 10.1515/dx-2021-0080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Li H, Chen L, Ke ZB, Chen SH, Xue XY, Zheng QS, Wei Y, Zeng K, Xu N. Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients. Int J Gen Med 2021;14:6325-42. [PMID: 34629897 DOI: 10.2147/IJGM.S332732] [Reference Citation Analysis]
12 Feldman AS, Lokeshwar V, Lin DW. A 25-year perspective on evaluation and understanding of biomarkers in urologic cancers. Urol Oncol 2021:S1078-1439(21)00269-6. [PMID: 34315659 DOI: 10.1016/j.urolonc.2021.06.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Marchetti A, Rosellini M, Mollica V, Rizzo A, Tassinari E, Nuvola G, Cimadamore A, Santoni M, Fiorentino M, Montironi R, Massari F. The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory? Int J Mol Sci 2021;22:6237. [PMID: 34207825 DOI: 10.3390/ijms22126237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]